商品簡介
Designed for scholars and students of legal studies, this book looks at legal systems in the US and Europe that deal with biotechnology, especially the question of whether a living organism or its parts can be patented. The legal system in the US gives priority to technical evaluation, as with patent applications for machines; the primary question is whether commercial use is technically feasible and who should profit from it as the inventor. The legal system in Europe considers questions of fundamental rights and bioethics. The book looks at the structure of each system, and problematic areas in each. It ends with recommendations for how to balance regulations on biotechnology to guarantee both returns for investors and access to information. As current corporate-university partnerships in the US frequently leave researchers with pressure to falsify research to support industry goals or restrictions on sharing their results with other researchers for scientific advancement, the book will have a secondary readership among US scholars and scientists who work in biotechnology. The book's language is suitable for experienced academic readers who wish to better understand existing systems of law and exception, and improve the regulation of biotechnology partnerships for mutual benefit. Annotation c2015 Ringgold, Inc., Portland, OR (protoview.com)
作者簡介
Andrea Stazi, Department of Human Sciences, European University of Rome, Italy
